期刊文献+

托特罗定治疗膀胱过度活动症 被引量:12

下载PDF
导出
摘要 托特罗定(tolterodine)是一种新型膀胱过度活动症治疗药,选择性作用于膀胱,能有效改善患者的尿频、尿急和急迫性尿失禁等症状,且不良反应较少。
作者 杨惠娣 徐彬
出处 《世界临床药物》 CAS 2003年第9期565-568,共4页 World Clinical Drug
  • 相关文献

参考文献17

  • 1Guay DRP.Tolterodine, a new antimuscari nic drug for treatment of bladder overactivity[J],1999(03).
  • 2Appell RA.Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis[J],1997(z1).
  • 3Lawrence M;Benson SR;Anderson MJ.Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis[J],2000(04).
  • 4Michel MC;Schneider T;Krege S.Does gender or age affect the efficacy and safety of tolterodine[J],2002(03).
  • 5Millard R;Tuttle J;Moore K.Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity[J],1999(05).
  • 6Nilvebrant L;Sundpuist S;Gillbery PG.Tolterodine is not subtype selective but exihibits functional bladder selectivity in vivo,1996(04).
  • 7Brynne N;Stahl MMS;Hallen B.Pharmaeokinetics and pharmacody namics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity,1997(07).
  • 8Nilvebrant L;Andersson KE;Gillberg PG.Tolterodine: a new bladderselective agent,1997.
  • 9Short DD.Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity - a comment[J],1999(10).
  • 10Bolduc S;Upadhyay J;Payton J.The use of tolterodine in children after oxybutynin failure[J],2003(04).

二级参考文献48

  • 1刘正和,张钧寿,曹德善.酒石酸托特罗定缓释片的研制[J].中国生化药物杂志,2004,25(4):230-232. 被引量:2
  • 2吕胜启,张杰.老年性尿失禁[J].世界临床药物,2003,24(11):673-676. 被引量:9
  • 3王东文,双卫兵.膀胱过度活动症[J].临床泌尿外科杂志,2005,20(7):445-447. 被引量:8
  • 4李正明,郑荣根,李刚,施国强,郑观恩,李颂,黄文胜.托特罗定治疗女性膀胱过度活动症26例疗效分析[J].岭南现代临床外科,2006,6(2):138-139. 被引量:4
  • 5国家药典委员.中国药典[M].200r7版.北京:中国医药科技出版社,2007.
  • 6Rovner ES,Wein AJ.Incidence and prevalence of overactive bladder[J].Curr Urol Rep,2002,3:434-438.
  • 7Milsom I,Abrams P,Cardozo L,et al.How widespread are the symptoms of anoveractive bladder and how are theymanaged?A population-based prevalence study[J].BJU Int,2001,87(9):760-766.
  • 8Cardozo L,Kuzmin I,Lisee M L,et al.YM905:Results of a randomized,double-blind placebo-controlled trial in patients with symptomatic overactive bladder[J].Eur Urol Suppl,2003,2(1):Abst 104.
  • 9Sorbera L A,Castaner J,Leeson P A.Fesoterodine[J].Drugs Fut,2003,28(7):647-651.
  • 10Ohyama Toshinori,Ohishi Masahiko,Yamamoto Yasuhiro,et al.Oral solid preparation:WO,0134147[P].2001-05-17.

共引文献21

同被引文献86

引证文献12

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部